Review of diagnostic plaque reduction neutralization tests for flavivirus infection

Veterinary Journal

Volumn 195, Issue 1, 2013, Pages 33-40

  Maeda, Akihiko ^a   Maeda, Junko ^b  

^a KYOTO SANGYO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Diagnostic; Differential serodiagnosis; Flavivirus; Plaque reduction neutralization test; Reporter virus particles

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; NONSTRUCTURAL PROTEIN 1; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; DENGUE; DENGUE VIRUS; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; ENZYME MODIFICATION; GEOGRAPHIC DISTRIBUTION; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFECTION RISK; JAPANESE ENCEPHALITIS; JAPANESE ENCEPHALITIS VIRUS; NONHUMAN; OUTCOME ASSESSMENT; PLAQUE REDUCTION NEUTRALIZATION TEST; PUBLIC HEALTH PROBLEM; REVIEW; SERODIAGNOSIS; VIRUS DETECTION; VIRUS GENOME; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS REPLICATION; WEST NILE FEVER; WEST NILE FLAVIVIRUS; ANIMAL; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; ISOLATION AND PURIFICATION; PROCEDURES; VETERINARY; VIRAL PLAQUE ASSAY;

ARTHROPODA; FLAVIVIRUS; JAPANESE ENCEPHALITIS VIRUS;

ANIMALS; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; GENOME, VIRAL; HUMANS; VIRAL PLAQUE ASSAY;

EID: 84871418780     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2012.08.019     Document Type: Review

References (58)

1. Alcon S., Talarmin A., Debruyne M., Falconar A., Deubel V., Flamand M. Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. Journal of Clinical Microbiology 2002, 40:376-381.
2. Barrett A.D.T., Monath T.P. Epidemiology and ecology of yellow fever virus. Advances in Virus Research 2003, vol. 61:291-315. Elsevier, California, USA.
3. Blitvich B.J., Fernandez-Salas I., Contreras-Cordero J.F., Marlenee N.L., Gonzalez-Rojas J.I., Komar N., Gubler D.J., Calisher C.H., Beaty B.J. Serologic evidence of West Nile virus infection in horses, Coahuila State, Mexico. Emerging Infectious Diseases 2003, 9:853-856.
4. Briese T., Jia X.Y., Huang C., Grady L.J., Lipkin W.I. Identification of a Kunjin/West Nile-like flavivirus in brains of patients with New York encephalitis. Lancet 1999, 354:1261-1262.
5. Bressanelli S., Stiasny K., Allison S.L., Stura E.A., Duquerroy S., Lescar J., Heinz F.X., Rey F.A. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO Journal 2004, 23:728-738.
6. Calisher C.H., Karabatsos N., Dalrymple J.M., Shope R.E., Porterfield J.S., Westaway E.G., Brandt W.E. Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera. Journal of General Virology 1989, 70:37-43.
7. Calisher C.H., Gould E.A. Taxonomy of the virus family Flaviviridae. Advances in Virus Research 2003, vol. 59:1-17. Elsevier, California, USA.
8. CDC, 2001. Requirements for facilities transferring or receiving select agents. Final rule. Federal Register 66, 45944-45945.
9. Chu J.J., Ng M.L. Interaction of West Nile virus with alpha v beta 3 integrin mediates virus entry into cells. Journal of Biological Chemistry 2004, 279:54533-54541.
10. Edelman R., Nisalak A., Pariyanonda A., Udomsakdi S., Johnsen D.O. Immunoglobulin response and viremia in dengue-vaccinated gibbons repeatedly challenged with Japanese encephalitis virus. American Journal of Epidemiology 1973, 97:208-218.
11. Fayzulin R., Scholle F., Petrakova O., Frolov I., Mason P.W. Evaluation of replicative capacity and genetic stability of West Nile virus replicons using highly efficient packaging cell lines. Virology 2006, 351:196-209.
12. Foral T.M., French R.A., van Kruiningen H.J., Garmendia A.E. Fluorescent antibody test for rapid detection of West Nile virus antigen in avian tissues. Avian Diseases 2007, 51:601-605.
13. Francis T., Salk J.E., Quilligan J.J. Experience with vaccination against influenza in the spring of 1947; a preliminary report. American Journal of Public Health 1947, 37:1013-1016.
14. Gould E.A., Solomon T. Pathogenic flaviviruses. Lancet 2008, 371:500-509.
15. Gritsun T.S., Nuttall P.A., Gould E.A. Tick-borne flaviviruses. Advances in Virus Research 2003, vol. 61:318-371. Elsevier, California, USA.
16. Gubler D.J. Epidemic dengue and dengue hemorrhagic fever: A global public health problem in 21st century. Emerging Infections 1998, vol. 1:1-14. ASM Press, Washington, DC.
17. Gubler, D.J., Kuno, G., Markoff, L., 2007. Flaviviruses. In: Knipe, D.M., Howley, P.M., Griffin, D., Lam, R.A., Martin, M.A., Roizman, B., Straus, S.E. (Eds.), Fields Virology. Lippincott, Williams and Wilkins, UK, pp. 1153-1252.
18. Gubler D.J. Flaviviruses: Past, present and future. Molecular Virology and Control of Flaviviruses 2012, 1-7. Caister, Norfolk, UK. P.-Y. Shi (Ed.).
19. Halstead S.B., Jacobson J.J. Japanese encephalitis. Advances in Virus Research 2003, vol. 61:103-138. Elsevier, California, USA.
20. HHS Biosafety in Microbiological and Biomedical Laboratories 2007, US Government Printing Office, Washington, DC. Fifth Ed.
21. Hogrefe W.R., Moore R., Lape-Nixon M., Wagner M., Prince H.E. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (prM/E) for detection of West Nile virus- and other flavivirus-specific antibodies. Journal of Clinical Microbiology 2004, 42:4641-4648.
22. ICTV, 2011. Family Flaviviridae. In: King, A.M.Q., Adams, M.J., Carstens, E.B., Lefkowitz, E.J. (Eds.), Virus Taxonomy, Ninth Report of the International Committee on Taxonomy of Viruses. Elsevier, San Diego, pp. 1003-1010.
23. Johnson B.W., Kosoy O., Hunsperger E., Beltran M., Delorey M., Guirakhoo F., Monath T. Evaluation of chimeric Japanese encephalitis and Dengue viruses for use in diagnostic plaque reduction neutralization tests. Clinical Vaccine and Immunology 2009, 16:1052-1059.
24. Komar N. West Nile virus: Epidemiology and ecology in North America. Advances in Virus Research 2003, vol. 61:185-234. Elsevier, California, USA.
25. Kuno G., Gubler D.J., Oliver A. Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections. Transaction of the Royal Society of Tropical Medicine and Hygiene 1993, 87:103-105.
26. Kuno G. Serodiagnosis of flaviviral infections and vaccinations in humans. Advances in Virus Research 2003, vol. 61:3-65. Elsevier, California, USA.
27. Kuno G., Chang G.-J. Biological transmission of arboviruses: Reexamination of and new insight into components, mechanisms, and unique traits as well as their evolutionary trends. Clinical Microbiology Review 2005, 18:608-637.
28. Leardkamolkarn V., Sirgulpanit W., Chotiwan N., Kumkate S., Huang C.Y. Development of Dengue type-2 virus replicons expressing GFP reporter gene in study of viral RNA replication. Virus Research 2012, 163:552-562.
29. Ledermann J.P., Lorono-Pino M.A., Ellis C., Saxton-Shaw K.D., Blitvich B.J., Beaty B.J., Bowen R.A., Powers A.M. Evaluation of widely used diagnostic tests to detect West Nile virus infections in horses previously infected with St. Louis encephalitis virus or dengue virus type 2. Clinical Vaccine and Immunology 2011, 18:580-587.
30. Lindenbach, B., Rice, C., 2001. Flaviviridae: The viruses and their replication. In: Knipe, D., Howley, P. (Eds.), Fields Virology, vol. 1. Lippincott Williams and Wilkins, Philadelphia, PA, pp. 991-1042.
31. Mackenzie J.S., Gubler D.J., Petersen L.R. Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nature Medicine 2004, 10:S98-S109.
32. Maeda J., Takagi H., Hashimoto S., Kurane I., Maeda A. A PCR-based protocol for generating West Nile virus replicons. Journal of Virological Methods 2008, 148:244-252.
33. Malan A.K., Stipanovich P.J., Martins T.B., Hill H.R., Litwin C.M. Detection of IgG and IgM to West Nile virus. Development of an immunofluorescence assay. American Journal of Clinical Pathology 2003, 119:508-515.
34. Mansfield K.L., Horton D.L., Johnson N., Li L., Barrett A.D.T., Smith D.J., Galbraith S.E., Solomon T., Fooks A.R. Flavivirus-induced antibody cross-reactivity. Journal of General Virology 2011, 92:2821-2829.
35. Martin D.A., Muth D.A., Brown T., Johnson A.J., Karabatsos N., Roehrig J.T. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. Journal of Clinical Microbial 2000, 38:1823-1826.
36. Mattia K., Puffer B.A., Williams K.L., Gonzalez R., Murray M., Sluzas E., Pagono D., Ajith S., Bower M., Berdougo E., Harris E., Doranz B.J. Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. Pros ONE 2011, 6:e27252.
37. Misra U.K., Kalita J. Overview: Japanese encephalitis. Progress in Neurobiology 2010, 91:108-120.
38. Monath T.P., McCarthy K., Bedford P., Johnson C.T., Nichols R., Yoksan S., Marchesani R., Knauber M., Wells K.H., Arroyo J., Guirakhoo F. Clinical proof of principle for ChimeriVax: Recombinant live, attenuated vaccines against flavivirus infections. Vaccine 2002, 20:1004-1018.
39. Morales M.A., Barrandeguy M., Fabbri C., Garcia J.B., Vissani A., Trono K., Gutierrez G., Pigretti S., Menchaca H., Garrido N., Taylor N., Fernandez F., Levis S., Enrio D. West Nile virus isolation from equines in Argentina, 2006. Emerging Infectious Diseases 2006, 12:1559-1561.
40. Moritoh K., Maeda A., Nishino T., Sasaki N., Agui T. Development and application of West Nile virus subgenomic replicon RNA expressing secreted alkaline phosphatase. Journal of Veterinary Medical Sciences 2011, 73:683-686.
41. Nagarkatti P.S., Nagarkatti M. Comparison of haemagglutination (HI) and indirect fluorescent antibody (IFA) techniques for the serological diagnosis of certain flavivirus infection. The American Journal of Tropical Medicine and Hygiene 1980, 83:115-117.
42. Pepperell C., Rau N., Krajden S., Kern R., Humar A., Mederski B., Simor A., Low D.E., McGeer A., Mazzulli T., Burton J., Jaigobin C., Fearon M., Artsob H., Drebot M.A., Halliday W., Brunton J. West Nile virus infection in 2002: Morbidity and mortality among patients admitted to hospital in south-central Ontario. Canadian Medical Association Journal 2003, 168:1399-1405.
43. Pfeffer M., Dobler G. Emergence of zoonotic arboviruses by animal trade and migration. Parasites and Vectors 2010, 3:35-49.
44. Pugachev K.V., Guirakhoo F., Mitchell F., Ocran S.W., Parsons M., Johnson B.W., Kosoy O.L., Lamciotti R.S., Roehrig J.T., Trent D.W., Monath T.P. Construction of yellow fever/St. Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool. The American Journal of Tropical Medicine and Hygiene 2004, 71:639-645.
45. Ravi V., Desai A.S., Shenoy P.K., Satishchandra P., Chandramuki A., Gourie-Devi M. Persistence of Japanese encephalitis virus in the human nervous system. Journal of Medical Virology 1993, 40:326-329.
46. Rice C.M., Lenches E.M., Eddy S.R., Shin S.J., Sheets R.L., Strauss J.H. Nucleotide sequence of yellow fever virus: Implications for flavivirus gene expression and evolution. Science 1985, 229:726-733.
47. Roehrig J.T., Hombach J., Barrett A.D.T. Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunology 2008, 21:123-132.
48. Smithburn K.C., Hughes T.P., Burke A.W., Paul J.H. A neurotropic virus isolated from the blood of a native of Uganda. The American Journal of Tropical Medicine and Hygiene 1940, 20:471-492.
49. Solomon T., Dung N.M., Kneen R., Gainsborough M., Vaughn D.W., Khanh V.T. Japanese encephalitis. Journal of Neurology and Neurosurgery and Psychiatry 2000, 68:405-415.
50. Tassaneetrithep B., Burgess T.H., Granelli-Piperno A., Trampfheller C., Finke J., Sun W., Eller M.A., Patthanapanyasat K., Sarasombath S., Birx D.L., Steinman R.M., Schlesinger S., Marovich M.A. DC-SIGN (CD209) mediates dengue virus infection on human dendritic cells. The Journal of Experimental Medicine 2003, 197:823-829.
51. Thomas S.J., Strickman D., Vaughn D.W. Dengue epidemiology: Virus epidemiology, ecology, and emergence. Advances in Virus Research 2003, vol. 61:235-289. Elsevier, California, USA.
52. Virelizier J.-L., Allison A.C., Schild G.C. Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: A bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. The Journal of Experimental Medicine 1974, 140:1571-1578.
53. Westaway E.G. Greater specificity of 19S than 7S antibodies on haemagglutination-inhibition tests with closely related group B arboviruses. Nature 1968, 219:78-79.
54. WHO WHO-Recommended Standards for Surveillance of Selected Vaccine-Preventable Diseases 2003, WHO, Geneva, Switzerland.
55. WHO, 2007. Guidelines for Plaque Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. WHO, Geneva, Switzerland.
56. Weaver S.C., Reisen W.K. Present and future arboviral threats. Antiviral Research 2010, 85:328-345.
57. Xu H., Di B., Pan Y.-X., Qiu L.-W., Wang Y.-D., Hao W., He L.-J., Yuen K.-Y., Che X.-Y. Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections. Journal of Clinical Microbiology 2006, 44:2872-2878.
58. Yu I.-M., Zhang W., Holdaway H.A., Li L., Kostyuchenko V.A., Chipman P.R., Kuhn R.J., Rossmann M.G., Chen J. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 2008, 319:1834-1837.